Revenue and EBITDA declined year-over-year, but margins rebounded in Q3 2024. Major investments and acquisitions expanded capacity, with strong growth in RDF and stabilization segments. Regulatory trends and market demand support positive outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.